最終更新日: 8月 15, 2026
Syphilis is one of the sexually transmitted infections I see regularly. How it presents depends on the stage — a painless genital ulcer early on, a rash on the palms and soles later. A blood test is the only way to confirm the diagnosis, and that is where the confusion starts, because there are two different families of blood test and each has its own strengths and limits.
This matters more than a technical detail. Patients who receive a positive result without a full explanation often leave badly frightened, and end up going from clinic to clinic looking for a second opinion that says something different. Understanding what each test actually measures usually removes the fear entirely.

1. Nontreponemal tests — the screening tests
These are used first, when syphilis is suspected. Their strength is that they reflect active infection, which also makes them the tests used to check whether treatment is working.
- VDRL (Venereal Disease Research Laboratory)
- RPR (Rapid Plasma Reagin)
Their weakness is that they can turn positive when there is no syphilis at all — a biological false positive, which several other conditions can cause. That is precisely why a positive screening test is never the end of the story. They can also read falsely negative very early in infection, before antibodies have developed, so a recent exposure with a negative result may need repeating.
2. Treponemal tests — the confirmation tests
If a VDRL or RPR comes back positive, the diagnosis has to be confirmed with a treponemal test.
- TP-PA (Treponema Pallidum Particle Agglutination)
- FTA-ABS (Fluorescent Treponemal Antibody Absorbed)
These are highly accurate for syphilis. Their limitation is the one that causes the most distress: a treponemal test stays positive for the rest of your life, even after the infection has been completely cured. It tells you that you have encountered syphilis at some point — not that you have it now. This is why treatment can never be judged by a treponemal test alone.
Reading the two together
The practical rule is simple once you have it: the confirmation test answers whether it was ever syphilis, and the screening test answers whether it is active now and whether the treatment is working. Treatment response is followed by watching the VDRL or RPR titre fall over the months after treatment. A permanently positive treponemal test alongside a falling titre is exactly what a successfully treated patient looks like.

Two practical points that follow from all this. A confirmed diagnosis means current sexual partners need testing and treatment as well, whatever your own result now shows. And because syphilis travels in company, testing for other sexually transmitted infections at the same time is standard rather than an extra.
Syphilis is a very treatable infection — treatment is straightforward when it is done correctly. What turns it into a frightening experience is usually not the disease but the test results arriving without an explanation. If you have a positive result and nobody has walked you through what it means, ask. Once you can read your own results, the panic tends to disappear.
梅毒の血液検査の結果に懸念がある場合、または性感染症の診断と治療が必要な場合は、ソアラウィー・ウィーラソポーン医師がバンコク・ホスピタル・ヘッドクォーターズで秘密厳守の専門医による診察を提供しています。. 診療をご予約. サミティウェート・シーラチャ病院のご予約は、泌尿器科(電話番号:)までお問い合わせください。 088-022-1445.
梅毒血液検査に関するよくある質問
非トレポネーマ検査(VDRL、RPR)は、活動性の梅毒感染を検出し、治療反応をモニタリングするためのスクリーニング検査として使用されます。トレポネーマ検査(TP-PA、FTA-ABS)は、梅毒に高い特異性を持つ確認検査ですが、治療が成功した後でも生涯陽性であるため、単独で治療成績を評価することはできません。.
陽性のVDRLまたはRPRは強力な指標となりますが、確定診断ではありません。これらのスクリーニング検査は、自己免疫疾患やウイルス感染症などの他の病状により、偽陽性となることがあります。梅毒の確定診断には、常に確認のためのトレポネーマ検査(TP-PAまたはFTA-ABS)が必要です。.
トレポネーマ検査は、梅毒菌に対する特異的な抗体を検出します。この抗体は、産生されると一生涯血中に残存し、感染が完全に治癒した後も検出されます。これは正常な所見であり、感染がまだ活動していることを意味するものではありません。治療の成功は、非トレポネーマ検査(VDRLまたはRPR)を使用して監視され、効果的な治療後には抗体価の低下が見られるはずです。.
治療効果は、時間経過とともにVDRLまたはRPRの力価をモニターすることで追跡されます。治療が成功した後、非トレポネーマ検査の力価は6〜12ヶ月以内に4倍以上に減少するはずです。力価が安定しているか上昇している場合は、治療失敗または再感染を示唆する可能性があり、専門医によるさらなる評価が必要です。.
Yes, syphilis is highly curable, especially when diagnosed and treated early. The standard treatment is penicillin G injection, with the dose and duration depending on the stage of infection. Early diagnosis, correct treatment, and regular follow-up blood tests are essential to ensure complete cure and prevent complications or transmission to partners. Current sexual partners should be tested and treated as well.
免責事項 This content is written and reviewed by Dr. Soarawee Weerasopone, a board-certified urologist at Bangkok Hospital Headquarters. It is intended for educational purposes only and does not constitute medical advice. Blood test results must be interpreted by a doctor who knows your history — do not draw conclusions about your own results from this article alone. No medical advice, diagnosis or prescription is provided through personal messaging channels. Always consult a qualified healthcare professional before starting any medical treatment.
医学的に記述・監修: Dr. Soarawee Weerasopone (Dr. Pom) — Board-Certified Urologist, Bangkok Hospital Headquarters, in urological practice since 2016. Fellowship: Robotic Surgery, Chang Gung Memorial Hospital, Taiwan (2019) · Observership: Endourology, Juntendo University Hospital, Tokyo (2022) · Research Scholar & Clinical Observer, Scott Department of Urology, Baylor College of Medicine, USA (2025–2026).

Dr. Soarawee Weerasopone (Dr. Pom) is a board-certified urologist at Bangkok Hospital Headquarters, specializing in Men’s Health, Robotic Surgery (da Vinci Xi) and Kidney Stone treatment. He is currently a Research Scholar and Clinical Observer at the Scott Department of Urology, Baylor College of Medicine (2025–2026), under Prof. Mohit Khera. He completed a Robotic Surgery Fellowship at Chang Gung Memorial Hospital, Taiwan (2019) and an Endourology Observership at Juntendo University Hospital, Tokyo (2022).

